On April 18th BC PharmaCare announced that it was expanding its existing coverage of medications for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in the paediatric population only. Three long acting ADHD medications (Adderall XR, Vyvanse and Strattera) will be added under the Special Authority (SA) program. CADDRA and CADDAC along with BC medical practitioners welcome these expanded medication options for children. However, British Columbia continues to lag significantly behind other provinces by denying coverage to individuals over 19, thereby discriminating against adults with ADHD.
Read More on our Blog
May 2, 2017 Media Releases
If you’re an adult with ADHD, your skills and weak... Read More
Workshop Request Form While those with Attention D... Read More
Many adults with ADHD can perform their jobs succe... Read More
Alison is a mother of an ADHD teenager, a health s... Read More
When I was 3 years old, I was expelled from presch... Read More